Tail Of The Ventral Tegmental Area Neurons is an important cell type in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
The Tail of the Ventral Tegmental Area (tVTA), also known as the rostral linear nucleus or linear nucleus, is a posterior extension of the VTA that interfaces with the dorsal raphe nucleus. It plays critical roles in aversion, nicotine addiction, and mood regulation.
- Midbrain: Posterior to the VTA, at the junction with the dorsal raphe
- Boundaries: Medial lemniscus laterally, dorsal raphe dorsally
- Subdivisions: Multiple subregions with distinct connectivity
- Dopaminergic neurons: Subpopulation projecting to specific targets
- GABAergic neurons: Major inhibitory population
- Glutamatergic neurons: Emerging population
- Tyrosine hydroxylase (TH): Dopaminergic identity
- VGlut2 (SLC17A6): Glutamatergic markers
- GAD67 (GAD1): GABAergic markers
- Calretinin: Calcium-binding protein
- Somatostatin: Neuropeptide marker
- Negative reward: Responds to aversive stimuli
- Reward prediction errors: Signals negative prediction errors
- Avoidance learning: Drives avoidance behaviors
- Nicotine response: High sensitivity to nicotine
- Withdrawal aversion: Hyperactivity during nicotine withdrawal
- Addiction circuitry: Key node in nicotine dependence
- Depression linkage: tVTA hyperactivity in depression
- Serotonergic interactions: Close relationship with dorsal raphe
- Anhedonia: Dysfunction in reward processing
- Non-motor symptoms: Depression and anxiety
- Anhedonia: Reward circuit dysfunction
- Olfactory deficits: Connections to olfactory circuits
- Mood symptoms: Early depression
- Motivation: Reward system changes
- Apathy: Frontal-striatal circuits
- Psychiatric symptoms: Depression and irritability
- Reward processing: Early changes
- Target: Deep brain stimulation
- Pharmacology: Nicotinic antagonists
- Ketamine: Rapid antidepressant effects may involve tVTA
- Nicotine: Primary target
- Other substances: Alcohol, opioids
- Treatment: Varenicline, bupropion
The study of Tail Of The Ventral Tegmental Area Neurons has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
- Jhou, T.C. et al. (2023). Neural circuits of the tail of the VTA. Nat Neurosci
- Kaufling, J.W. et al. (2022). Aversive signals and the tail of VTA. J Neurosci
- Nashmi, R. & Jones, I.G. (2021). Nicotine and the tail of VTA. Neuropsychopharmacology
- Stamatakis, A.M. et al. (2020). Reward and aversion in the tail VTA. Neuron
- Yang, H. et al. (2021). Depression and the tail VTA. Biol Psychiatry
- Friedman, A.K. et al. (2022). Optogenetic manipulation of tVTA. Nat Med